The antiplatelet effect of daily low dose enteric-coated aspirin in man: A time course of onset and recovery
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 59 (6) , 995-1005
- https://doi.org/10.1016/0049-3848(90)90123-t
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteersThrombosis Research, 1989
- Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet functionEuropean Journal of Clinical Pharmacology, 1988
- A DOSE‐RANGING STUDY OF THE ANTIPLATELET EFFECT OF ENTERIC COATED ASPIRIN IN MANAustralian and New Zealand Journal of Medicine, 1987
- Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?Clinical Science, 1986
- Aspirin and the StomachAnnals of Internal Medicine, 1986
- Cumulative antiplatelet effect of low‐dose enteric coated aspirinBritish Journal of Haematology, 1985
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- ASPIRIN AND PLATELETSThe Lancet, 1980
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976